Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.

[1]  P. Chang,et al.  Acute vasodilator action of pindolol in humans. , 1985, Hypertension.

[2]  A. J. Man in't veld,et al.  Splint renal function after captopril in unilateral renal artery stenosis. , 1984, British medical journal.

[3]  P. Korner.  Beta-blockers, autoregulation, and experimental design. , 1984, Hypertension.

[4]  S. Julius,et al.  Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents. , 1984, Hypertension.

[5]  A. Cowley.  Assessment of the contributions of autoregulatory mechanisms to the antihypertensive actions of beta-adrenergic therapy. , 1984, Hypertension.

[6]  M. Schalekamp,et al.  Effects of 10 Different β‐Adrenoceptor Antagonists on Hemodynamics, Plasma Renin Activity, and Plasma Norepinephrine in Hypertension: The Key Role of Vascular Resistance Changes in Relation to Partial Agonist Activity , 1983, Journal of cardiovascular pharmacology.

[7]  A. J. Man in 't Veld,et al.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism. , 1982, British journal of clinical pharmacology.

[8]  B. J. Clark,et al.  Pindolol--the pharmacology of a partial agonist. , 1982, British journal of clinical pharmacology.

[9]  S. Taylor,et al.  Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful? , 1982, The New England journal of medicine.

[10]  F. Frey,et al.  Estimation of transcortin concentration by measurements of plasma protein-binding of prednisolone and by electroimmunodiffusion. , 1982, British journal of clinical pharmacology.

[11]  E. Raftery,et al.  Once daily beta-adrenoceptor blockade in hypertension: an ambulatory assessment. , 1981, British journal of clinical pharmacology.

[12]  A. J. Man in 't Veld,et al.  Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications. , 1981, British medical journal.

[13]  J. Cohn,et al.  Short‐Term Systemic Hemodynamic Adaptation to Beta‐Adrenergic Inhibition with Atenolol in Hypertensive Patients , 1981, Hypertension.

[14]  W. MacIntyre,et al.  Automated computer program for radionuclide cardiac output determination. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  A. J. Man in 't Veld,et al.  Quantitative radiocardiography by single-probe counting using 99mtechnetium albumin: clinical application in follow-up studies. , 1978, The Netherlands journal of medicine.

[16]  J. Atterhög,et al.  Experience with pindolol, a betareceptor blocker, in the treatment of hypertension. , 1976, The American journal of medicine.

[17]  C. Johnston,et al.  The relationship of plasma levels of pindolol in hypertensive patients to effects on blood pressure, plasma renin and plasma noradrenaline levels , 1975, Clinical and experimental pharmacology & physiology.

[18]  R. Tarazi,et al.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. , 1972, The American journal of cardiology.

[19]  W. Birkenhäger,et al.  Abnormal renal haemodynamics and renin suppression in hypertensive patients. , 1970, Clinical science.

[20]  Bevan At,et al.  Direct arterial pressure recording in unrestricted man. , 1969 .